Abstract:The participation of nerve growth factor (NGF) as a trophic factor for cholinergic neurons of the basal forebrain and the selective degeneration of ascending cholinergic projections from the basal forebrain in Alzheimer's disease have led to the hypothesis that reductions in NGF may contribute to the pathogenesis of Alzheimer's disease.' The intraventricular administration of antisera for NGF to rats results in histologic degeneration of the septohippocampal projection that is reminiscent of Alzheimer's disease.* We report preliminary data of a pilot study using an enzyme-linked immunosorbent assay (ELISA) to detect antibody with reactivity for NGF. Five patients meeting criteria for primary degenerative dementia (Alzheimer's disease, AD) according to the American Psychiatric Association Diagnostic Statistical Manual, Third Edition 1980 (DSM-111) and ageand sex-matched elderly normal volunteers (n = 3) were studied. Subjects were free of chronic medication for at least a 3-week period before the drawing of blood samples. The investigators were blind to diagnoses. The ELISA was performed as previously described? Antibodies with reactivity for NGF were purified by affinity chromatography from three of five patients with AD (TABLE 1 ). The purified antibodies of normal volunteers demonstrated minimal reactivity at equivalent IgG concentrations. However, antibody that reacted with NGF at higher concentrations was recovered from normal volunteer 3. Purified anti-NGF IgG from a patient with AD and a normal volunteer immunoprecipitated 50% and 5% of soluble ['"-1]2.5S NGF, respectively. The binding of F(ab'), fragment of anti-NGF IgG from a patient with AD was inhibited by 36% by M 2.5s NGF. The ELISA was modified and employed to detect binding of purified antibodies to rat brain membranes. Anti-NGF IgG from a patient with AD demonstrated 72% greater binding to rat cortex than to rat midbrain-cerebellum (TABLE 2). This binding was reduced 36% by the addition of soluble 2.5s NGF ( 5 X M) to the antiNGF IgG. A qualitatively similar but quantitatively less reactive anti-NGF IgG recovered from an age-matched normal volunteer demonstrated less binding to rat brain at higher concentrations; its binding to rat cortex was inhibited by 80% following the addition of soluble 2.5s NGF to the antibody. Theoretically, disordered regulation of an idiotypic network for NGF and its receptor might potentially induce the pathologic and neurochemical alterations in the

Antibody for Nerve Growth Factor Detected in Patients with Alzheimer's Disease

Novel advances in inhibiting advanced glycation end product formation using natural compounds

Embryonic development of the skull of the Andean lizard Ptychoglossus bicolor (Squamata, Gymnophthalmidae)

Investigations of AGEs’ inhibitory and nephroprotective potential of ursolic acid towards reduction of diabetic complications

Basal metabolic rate is decreased in women with polycystic ovary syndrome and biochemical hyperandrogenemia and is associated with insulin resistance.

THE AETIOLOGY OF DIVERTICULOSIS OF THE COLON WITH SPECIAL REFERENCE TO THE ACTION OF CERTAIN DRUGS ON THE BEHAVIOUR OF THE COLON.

Anyone Can Build Chua's Circuit: Hands-on-Experience with Chaos Theory for High School Students

Tetrahedral Framework Nucleic Acids Based Small Interfering RNA Targeting Receptor for Advanced Glycation End Products for Diabetic Complications Treatment

A review on mechanism of inhibition of advanced glycation end products formation by plant derived polyphenolic compounds

Fluorinated indeno-quinoxaline bearing thiazole moieties as hypoglycaemic agents targeting α-amylase, and α-glucosidase: synthesis, molecular docking, and ADMET studies

Synthesis and Evaluation of Antidiabetic Potential of Gliptin‐based Hybrid Scaffolds

Ultrasound‐Assisted Synthesis of Pyrazoline Derivatives as Potential Antagonists of RAGE‐Mediated Pathologies: Insights from SAR Studies and Biological Evaluations

Synthesis and bio-evaluation of newer dihydropyridines and tetrahydropyridines based glycomimetic azasugars

Synthesis and biological ( in vitro and in silico ) screening of the 4-aryl-fused pyranopyrazole derivatives as enzyme (α-amylase, α-glucosidase, acetylcholinesterase & proteinase) inhibitors with anti-oxidant and cytotoxic activities

Advanced Glycation End Products-Induced Alzheimer's Disease and Its Novel Therapeutic Approaches: A Comprehensive Review

Mechanisms of inhibition of advanced glycation end-products (AGEs) and α-glucosidase by Heliotropium bacciferum: Spectroscopic and molecular docking analysis

Quinoline- and Isoindoline-Integrated Polycyclic Compounds as Antioxidant, and Antidiabetic Agents Targeting the Dual Inhibition of α-Glycosidase and α-Amylase Enzymes

Design, synthesis, α -amylase and glucose diffusion inhibition, and molecular docking studies of new indenopyrazolones bearing benzothiazole derivatives

One-pot domino synthesis of 1H-isochromene and pyran carbonitrile from pyrazole aldehyde derivatives as potential anti-diabetic and antioxidant targets

Glycyrrhizic Acid Scavenges Reactive Carbonyl Species and Attenuates Glycation-Induced Multiple Protein Modification: An In Vitro and In Silico Study

Anti-Diabetic Activities and Molecular Docking Studies of Aryl-Substituted Pyrazolo[3,4-b]pyridine DerivativesSynthesized via Suzuki Cross-Coupling Reaction